Showing CypComp Card for CC00385: Repaglinide (CypReact Training Set)

Record Information
Version1.0
Creation Date2019-07-14 16:20:15 UTC
Last Updated2019-10-01 21:37:53 UTC
CypComp IDCC00385
Compound Information
NameRepaglinide
Structure ImageFaekwtjyaymjkf qhcpkhfhsa n
InChIKeyFAEKWTJYAYMJKF-QHCPKHFHSA-N
PubChem ID65981
CypCompound Information
SetCypReact Training Set
Reactant Statuses
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
Non-ReactantNon-ReactantNon-ReactantReactantNon-ReactantNon-ReactantNon-ReactantNon-ReactantReactant
References
  1. Bidstrup TB, Bjornsdottir I, Sidelmann UG, Thomsen MS, Hansen KT: CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide. Br J Clin Pharmacol. 2003 Sep;56(3):305-14. doi: 10.1046/j.0306-5251.2003.01862.x. [PubMed:12919179 ]
Download FileCC00385.sdf